Please visit our COVID-19 Resources page for more information on stroke care during the coronavirus pandemic. 

Clinical Research Studies

Top

The Institute for Stroke and Cerebrovascular Disease has implemented trials in the Texas Medical Center since the 1980's when neuroprotective agents for stroke were developed by our team. We have brought forward from our laboratories to clinical trials various new treatment approaches including transcranial ultrasound, adjunctive treatments with t-PA, medications that detoxify hematoma products in brain hemorrhage, and stem cells. We have successfully progressed many of these approaches to phase III clinical trial stages and continuously seek out next-level opportunities in research in our ultimate goals to better the lives of stroke patients and their loved ones.